The representative, In collaboration with various operational counterparts within the company and with external suppliers/vendors, Will ensure therapeutic strategy development and the clinical and operational launch of company sponsored studies, private investigator initiated studies and post marketing risk management research programs, involving in sourced, Outsourced or matrixed groups. single will focus on Phase II Phase IV studies, Post marketing risk management research programs and IIS trials to ensure strategic level plans are executed in a timely and compliant fashion for outcome of Medical Affairs' research goals. Manage and be chargeable for budgets for multiple therapeutic areas across the portfolio.

making use of the